Published in Am J Pathol on June 01, 1980
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A (1998) 1.58
AA-amyloidosis can be transferred by peripheral blood monocytes. PLoS One (2008) 1.03
Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ. Biophys J (2011) 0.81
Immunocytochemical study of hepatocyte synthesis of amyloid AA. Demonstration of usual site of synthesis and intracellular pathways but unusual retention on the surface membrane. Am J Pathol (1985) 0.77
Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice. Immunology (2004) 0.75
Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science (1971) 4.27
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96
Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med (1973) 3.22
Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest (1975) 3.17
Some factors in the development, localization and reabsorption of experimental amyloidosis in the rabbit. Am J Pathol (1941) 2.87
Chemical classes of amyloid substance. Am J Pathol (1971) 2.43
Amino acid sequence of monkey amyloid protein A. Biochemistry (1972) 2.17
Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol (1976) 1.97
The resorption of amyloid under experimental conditions. Am J Pathol (1954) 1.86
Current concepts of amyloid. Adv Immunol (1972) 1.75
Demonstration of amyloid fibrils in urinary sediment. N Engl J Med (1975) 1.65
Amyloidosis (concluded). N Engl J Med (1967) 1.64
The constitution and genesis of amyloid. Int Rev Exp Pathol (1965) 1.61
Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci U S A (1976) 1.60
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography. Arthritis Rheum (1975) 1.46
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest (1977) 1.45
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest (1977) 1.35
Remission of the nephrotic syndrome in renal amyloidosis. N Engl J Med (1970) 1.35
Animal model for human disease: spontaneous and induced amyloidosis. Am J Pathol (1972) 1.34
An analysis of the close relationship of lysosomes to early deposits of amyloid. Ultrastructural evidence in experimental mouse amyloidosis. Am J Pathol (1973) 1.22
Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse. J Immunol (1978) 1.22
Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink. J Exp Med (1976) 1.14
Renal transplantation in two cases of amyloidosis. Lancet (1971) 1.11
Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model. Immunology (1976) 1.09
Amyloid. IX. Further kinetic studies on experimental murine amyloidosis. Int Arch Allergy Appl Immunol (1970) 1.06
Histological studies in resorption of experimental amyloid. J Pathol Bacteriol (1967) 1.06
Lysosomal breakdown of amyloid fibrils by macrophages. Am J Pathol (1971) 0.99
Amylod resorption: possible role of multinucleated giant cells. The apparent failure of penicillamine treatment. Johns Hopkins Med J (1972) 0.84
Uncertain value of urinary sediments in the diagnosis of amyloidosis. N Engl J Med (1977) 0.81
Studies on the resorption of experimental amyloidosis. Br J Exp Pathol (1970) 0.81
Study of light-, electron- and immunofluorescence microscopy of urinary sediment in amyloidosis. Virchows Arch A Pathol Anat Histol (1978) 0.78
Amyloid in urinary sediments as a diagnostic technique. Ann Intern Med (1979) 0.77
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Equating health status measures with item response theory: illustrations with functional status items. Med Care (2000) 3.98
Review: history of the amyloid fibril. J Struct Biol (2000) 3.49
A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun (1985) 3.40
Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med (1976) 3.07
Amyloidosis. N Engl J Med (1967) 2.97
Acute arthritis caused by gram-negative bacilli: a clinical characterization. Medicine (Baltimore) (1974) 2.25
High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol (1967) 2.16
The pathogenesis and biochemistry of amyloidosis. J Pathol (1987) 2.15
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Treatment of septic arthritis: comparison of needle aspiration and surgery as initial modes of joint drainage. Arthritis Rheum (1975) 2.03
Blockage of amyloid induction by colchicine in an animal model. J Exp Med (1974) 1.96
Studies of immune deposits in synovial membranes and corresponding synovial fluids. J Lab Clin Med (1968) 1.90
Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) (1978) 1.83
A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med (1968) 1.80
Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum (1989) 1.76
Criteria for the classification of systemic lupus erythematosus--status 1972. Arthritis Rheum (1973) 1.71
Stabilization of Thylakoid Membranes by Spermine during Stress-induced Senescence of Barley Leaf Discs. Plant Physiol (1979) 1.70
Plasma protein constituents of amyloid fibrils. J Immunol (1967) 1.70
Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest (1990) 1.69
Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med (1969) 1.66
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Inflammatory synovitis in degenerative joint disease. J Rheumatol (1982) 1.65
Amyloidosis (concluded). N Engl J Med (1967) 1.64
Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63
Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience (2005) 1.61
The constitution and genesis of amyloid. Int Rev Exp Pathol (1965) 1.61
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis (1978) 1.54
Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum (1979) 1.53
The light and electron microscopic autoradiographic demonstration of local amyloid formation in spleen explants. Am J Pathol (1965) 1.52
Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography. Arthritis Rheum (1975) 1.46
The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum (1985) 1.46
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest (1977) 1.45
P-component (pentagonal unit) of amyloid: isolation, characterization, and sequence analysis. J Lab Clin Med (1974) 1.40
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Hereditary amyloidosis. Arthritis Rheum (1971) 1.38
Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol (1984) 1.38
Amyloid proteins, precursors, mediator, and enhancer. Lab Invest (1983) 1.38
Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med (1987) 1.37
In vitro formation of amyloid fibrils from intact beta 2-microglobulin. Biochem Biophys Res Commun (1985) 1.37
Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol (1982) 1.36
Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest (1977) 1.35
Animal model for human disease: spontaneous and induced amyloidosis. Am J Pathol (1972) 1.34
The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann N Y Acad Sci (1982) 1.33
The prealbumin nature of the amyloid protein in familial amyloid polyneuropathy (FAP)-swedish variety. Biochem Biophys Res Commun (1981) 1.32
Treatment of Wegener's granulomatosis with immunosuppressive agents. Description of renal ultrastructure. Arch Intern Med (1970) 1.29
The role of mucopolysaccharides in vesicle architecture and endothelial transport. An electron microscope study of myocardial blood vessels. J Cell Biol (1972) 1.29
Digoxin sensitivity in amyloid cardiomyopathy. Circulation (1981) 1.28
Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med (1971) 1.27
Arthritis associated with gonorrhoea. Ann Rheum Dis (1968) 1.26
Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury. Hippocampus (2006) 1.24
The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunology (1982) 1.23
Fine structural analysis of rabbit synovial cells. I. The normal synovium and changes in organ culture. Arthritis Rheum (1973) 1.23
An analysis of the close relationship of lysosomes to early deposits of amyloid. Ultrastructural evidence in experimental mouse amyloidosis. Am J Pathol (1973) 1.22
A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience (1999) 1.22
Bleeding manifestations in 100 patients with amyloidosis. JAMA (1983) 1.21
Tuberculous arthritis: A report of two cases with review of biopsy and synovial fluid findings. Am J Med (1976) 1.21
Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med (1975) 1.21
Amyloidosis: an expression of immunological tolerance? Lancet (1970) 1.20
The P-component of amyloid of human islets of langerhans. Scand J Immunol (1975) 1.20
Solubility characteristics of isolated amyloid fibrils. Biochim Biophys Acta (1965) 1.20
Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem (2001) 1.20
Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol Aging (1990) 1.19
Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer (1996) 1.18
Structure of amyloid fibrils after negative staining and high-resolution electron microscopy. Nature (1965) 1.17
Intralysosomal formation of amyloid fibrils. Am J Pathol (1975) 1.17
The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation. Prep Biochem (1982) 1.15
Patterns of pulmonary involvement in systemic amyloidosis. Chest (1978) 1.15
Herniation of mitral leaflets in the Ehlers-Danlos syndrome. Am J Cardiol (1975) 1.14
Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts. Ann Otol Rhinol Laryngol (1984) 1.14
Antigenic determinants in amyloid deposits. Nature (1970) 1.13
Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med (1988) 1.12
Amyloidosis. N Engl J Med (1967) 1.12
Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med (1977) 1.11
Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest (1982) 1.11
Renal transplantation in two cases of amyloidosis. Lancet (1971) 1.11
A new mutation causing familial amyloidotic polyneuropathy. Biochem Biophys Res Commun (1989) 1.11
Separation of DNA restriction fragments by high performance capillary electrophoresis with low and zero crosslinked polyacrylamide using continuous and pulsed electric fields. J Chromatogr (1990) 1.11
The evolution of the glomerular lesion in NZB mice. A light and electron microscopic study. Lab Invest (1968) 1.11
Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. Onderstepoort J Vet Res (2003) 1.11